Cargando…

The effect of infliximab on skin lesions in a patient with scleroderma (CREST)

Detalles Bibliográficos
Autores principales:	De Rycke, L, Baeten, D, Van den Bosch, F, Mielants, H, De Keyser, F, Veys, EM
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833776/ http://dx.doi.org/10.1186/ar1135

Ejemplares similares

Differential expression and response to infliximab treatment of specific macrophage subsets in inflammatory synovitis
por: De Rycke, L, et al.
Publicado: (2004)

Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment
por: De Rycke, L, et al.
Publicado: (2003)

The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
por: van Damme, N, et al.
Publicado: (2002)

Induction of ANA, anti-dsDNA and anti-nucleosome antibodies following infliximab treatment in rheumatoid arthritis and spondyloarthropathy patients
por: de Rycke, LEB, et al.
Publicado: (2002)

Myeloid-related protein (MRP) 8 and MRP 14 in rheumatoid arthritis and spondyloarthropathy
por: De Rycke, L, et al.
Publicado: (2003)

Serum MRP8/MRP14 as a biomarker for inflammation in autoimmune arthritis
por: De Rycke, L, et al.
Publicado: (2004)

The diagnostic value of synovial histopathology in undifferentiated inflammatory arthritis: a prospective study in 154 consecutive patients
por: Baeten, D, et al.
Publicado: (2003)

The presentation of the immunodominant epitope of HC gp-39 in the context of the RA-associated HLA class II molecules is specific for RA synovium
por: Baeten, D, et al.
Publicado: (2003)

Diagnostic performance and predictive value of serum markers for the diagnosis of rheumatoid arthritis
por: Hoffman, IEA, et al.
Publicado: (2004)

Local production of soluble CD163 in the spondyloarthropathic joint
por: Baeten, D, et al.
Publicado: (2003)

Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy
por: Baeten, D, et al.
Publicado: (2001)

Localisation of MHC Class II/HC gp-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies
por: Baeten, D, et al.
Publicado: (2003)

Sensitivity of ANA indirect immunofluorescence testing for the detection of anti-ENA antibodies
por: Hoffman, IEA, et al.
Publicado: (2002)

Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy
por: Baeten, Dominique, et al.
Publicado: (2005)

Association between ASCA-positivity and carrier of a CARD-15 mutation in patients with Crohn's disease
por: van der Cruyssen, B, et al.
Publicado: (2003)

Tumor necrosis factor-α blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?
por: Van den Bosch, Filip, et al.
Publicado: (2005)

Radiological sacroiliitis is linked with CARD15 gene polymorphisms in patients with Crohn's disease
por: Cruyssen, B Vander, et al.
Publicado: (2004)

Presence of anti-RNP-A and anti-RNP-C antibodies is inversely associated with renal symptoms of systemic lupus erythematosus
por: Hoffman, I, et al.
Publicado: (2003)

False positivity of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
por: Hoffman, IEA, et al.
Publicado: (2004)

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
por: Vander Cruyssen, Bert, et al.
Publicado: (2005)

The use of neural network algorithms for the classification of undifferentiated arthritis by synovial histopathology
por: Baeten, D, et al.
Publicado: (2003)

The presence of deiminated fibrin in the synovial membrane is not specific for rheumatoid arthritis
por: Chapuy-Regaud, S, et al.
Publicado: (2004)

Enhanced transendothelial in vitro migration of scleroderma lymphocytes
por: Stummvoll, GH, et al.
Publicado: (2001)

The Scleroderma Patient-centered Intervention Network for conducting large-scale international trials of nonpharmacological interventions in scleroderma: a way ahead for lupus?
por: Thombs, Brett D
Publicado: (2014)

Peptidylarginine deiminase isoforms expressed in the synovial membrane of rheumatoid arthritis patients
por: Chapuy-Regaud, S, et al.
Publicado: (2003)

Infliximab-graded challenge in a patient with Crohn’s disease and adalimumab hypersensitivity
por: Song, Christine H, et al.
Publicado: (2012)

Abnormal gene expression in CD8 T cells from the lungs of scleroderma patients
por: Luzina, IG, et al.
Publicado: (2002)

Infliximab induced anti-dsDNA: characteristics of autoantibody response
por: Charles, PJ, et al.
Publicado: (2002)

Refractory multisystem sarcoidosis involving pelvic bone responding to infliximab
por: Karjigi, Uma, et al.
Publicado: (2013)

Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, H, et al.
Publicado: (2003)

Shared epitope and rheumatoid arthritis severity: association with infliximab treatment in a postmarketing study
por: Marotte, H, et al.
Publicado: (2003)

Cross-talk between TRAIL and TGF-β in regulation of collagen production in scleroderma lung disease
por: Yurovsky, VV
Publicado: (2004)

Alveolar macrophages in scleroderma lung disease are activated by TGF-β and IL-4 but not TNF-α
por: Luzina, I, et al.
Publicado: (2003)

Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
por: Cruyssen, Bert Vander, et al.
Publicado: (2006)

Autoantibodies to the TNF-α translational regulators TIA-1 and TIAR occur frequently in sera of patients with SLE and scleroderma
por: Jimenez-Boj, E, et al.
Publicado: (2002)

Global analysis of gene expression in unseparated and CD8+ cells from bronchoalveolar lavage of patients with scleroderma lung disease
por: Luzina, IG, et al.
Publicado: (2001)

Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis
por: Mugnier, B, et al.
Publicado: (2004)

Infliximab treatment reduces synovial cellularity as early as 48 hours after initiation of treatment, but not by induction of apoptosis
por: Smeets, TJM, et al.
Publicado: (2003)

Successful treatment of infliximab in a patient with scleroderma: a case report
por: Li, Ting, et al.
Publicado: (2017)

Severe hemodynamic compromise, respiratory failure and disseminated skin lesions due to Strongyloides stercoralis
por: Mohovic, T, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_7dd94j3mqaoth8qp4p4st8rphh